SCHEDULE 13D: QT Imaging Holdings CEO Dr. Raluca Dinu Discloses 5.4% Beneficial Ownership Stake
Beneficial Ownership Disclosure
Dr. Raluca Dinu, CEO of QT Imaging Holdings, Inc., has filed a Schedule 13D disclosing beneficial ownership of 1,543,676 shares, representing 5.4% of the company's common stock.
Summary
- Dr. Raluca Dinu, who serves as a member of the Board and Chief Executive Officer of QT Imaging Holdings, Inc., has filed a Schedule 13D.
- She beneficially owns an aggregate of 1,543,676 shares of the Issuer's Common Stock.
- This ownership stake represents 5.4% of the total class of Common Stock, calculated based on 27,653,210 shares issued and outstanding as of March 28, 2025, as reported in the Issuer's Form 10-K filed on March 31, 2025.
- Her beneficial ownership comprises 775,570 shares of Common Stock owned directly, 571,440 shares from warrants exercisable within 60 days, and 196,666 shares from options exercisable within 60 days.
- The Reporting Person acquired these securities for investment purposes and intends to continuously review her investments in the Issuer.
Sentiment
Score: 6
Explanation: The filing is a factual disclosure of beneficial ownership by an insider. The CEO's significant stake (5.4%) can be viewed positively as it aligns her interests with shareholders, indicating confidence in the company. However, it provides no operational or financial performance details to significantly alter sentiment beyond this alignment.
Positives
- The disclosure provides transparency regarding a significant insider ownership stake by the CEO.
- The CEO's substantial beneficial ownership (5.4%) aligns her interests with those of the company's shareholders, potentially indicating confidence in the company's future.
Risks
- The Reporting Person reserves the right to acquire or dispose of securities of the Issuer at any time without prior notice.
- The Reporting Person may enter into hedging relationships with respect to such securities.
- The Reporting Person may formulate other purposes, plans, or proposals in the future, which could potentially impact the company's stock price or strategic direction.
Future Outlook
The Reporting Person intends to review her investments in the Issuer on a continuing basis. She reserves the right to acquire or dispose of securities, enter into hedging relationships, or formulate other purposes, plans, or proposals in the future, depending on market conditions and other factors.
Management Comments
- Dr. Dinu is currently a member of the Board and Chief Executive Officer of the Issuer.
Industry Context
This filing is a standard disclosure of beneficial ownership by a key insider, common across all publicly traded industries. In the medical imaging sector, such disclosures can be particularly scrutinized as they may reflect management's conviction in the company's technological advancements and market potential, especially for a company like QT Imaging Holdings, Inc. which operates in a specialized field.
Stakeholder Impact
- Shareholders: Provides transparency regarding the CEO's personal investment in the company, which may be interpreted as a sign of confidence in the company's prospects.
Next Steps
- The Reporting Person will continue to review her investments in the Issuer on an ongoing basis.
- The Reporting Person may acquire or dispose of securities of the Issuer in the future.
- The Reporting Person may enter into hedging relationships with respect to such securities.
- The Reporting Person may formulate other purposes, plans, or proposals in the future depending on market conditions and/or other factors.
Key Dates
| Date | Description |
|---|---|
| 03/21/2025 | Date of event which required the filing of this statement. |
| 03/28/2025 | Date as of which 27,653,210 shares of Common Stock were issued and outstanding, as reported in the Issuer's Form 10-K. |
| 03/31/2025 | Date the Issuer's Form 10-K was filed with the Securities and Exchange Commission. |
| 04/02/2025 | Date of filing of this Schedule 13D. |
Keywords
QT Imaging Holdings, Raluca Dinu, Schedule 13D, Beneficial Ownership, Insider Ownership, SEC Filing, Common Stock, QTI, Medical Imaging
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.